Huimin Yin, MSc candidate, presented her in vitro PDT work with tumour spheroids at the Beatrice Hunter Cancer Research Institute (BHCRI) conference in Halifax on November 5.

President and CEO of Theralase, Roger Dumoulin-White, discusses the Company's progress on  its ground breaking anti-cancer research on CBC’s The Lang and O’Leary Exchange. 

This article highlights the versatility of 3IL excited states in achieving potent PDT in cancer cells, but also against bacteria. Notably, this PDI effect extends to bacteria growing as a resilient biofilm.

Our licensed compound TLD-1433 has been identified as the lead photodynamic compound for human clinical trials!

Jordan Gibson and Mat Stephenson present posters of their Honours work at the 97th Canadian Chemistry Conference and Exhibition in Vancouver, BC!